A combination of faecal tests for the detection of colon cancer: a new strategy for an appropriate selection of referrals to colonoscopy? A prospective multicentre Italian study

No abstract is available for this paper.

• Publication year

  2012

• Venue

  European Journal of Gastroenterology and Hepathology

• Publication date

  2012-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MEG.0b013e328355cc79PMID 22735608
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dietary elimination therapy is an effective option for adults with eosinophilic esophagitis.

  2014cited by this paper
• Impact of a Population-Based Colorectal Cancer Screening Program on Local Health Services Demand in Italy: A 7-Year Survey in a Northern Province

  2011cited by this paper
• Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis

  2010cited by this paper
• Eight years of colonoscopic bowel cancer screening in Germany: initial findings and projections.

  2010cited by this paper
• Prevalence of adenomas and colorectal cancer in average risk individuals: a systematic review and meta-analysis.

  2009cited by this paper
• Screening for colorectal cancer in Italy: 2007 survey.

  2009cited by this paper
• Colorectal cancer screening in Europe: differences in approach; similar barriers to overcome

  2009cited by this paper
• Fecal dimeric M2‐pyruvate kinase (tumor M2‐PK) in the differential diagnosis of functional and organic bowel disorders

  2009cited by this paper
• Faecal occult blood test‐based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer

  2009cited by this paper
• Faecal dimeric M2 pyruvate kinase in colorectal cancer and polyps correlates with tumour staging and surgical intervention

  2008cited by this paper
• Comparison of an Established Simple Office-Based Immunological FOBT With Fecal Tumor Pyruvate Kinase Type M2 (M2-PK) for Colorectal Cancer Screening: Prospective Multicenter Study

  2008cited by this paper
• Regional Estimates of Colorectal Cancer Burden in Italy

  2007cited by this paper
• Tumour M2-pyruvate kinase: a gastrointestinal cancer marker

  2007cited by this paper
• Screening for colorectal cancer using the faecal occult blood test, Hemoccult.

  2007cited by this paper
• Tumour M2-PK as a stool marker for colorectal cancer: comparative analysis in a large sample of unselected older adults vs colorectal cancer patients

  2007cited by this paper
• Tumor pyruvate kinase isoenzyme type M2 and immunochemical fecal occult blood test: performance in screening for colorectal cancer

  2007cited by this paper
• Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data.

  2007cited by this paper
• Diagnostic value of faecal calprotectin in unselected outpatients referred for colonoscopy: A multicenter prospective study.

  2006cited by this paper
• Prospective multicenter evaluation of fecal tumor pyruvate kinase type M2 (M2‐PK) as a screening biomarker for colorectal neoplasia

  2006cited by this paper
• Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK.

  2006cited by this paper
• Estimates of the cancer incidence and mortality in Europe in 2006.

  2006cited by this paper
• A Simulation Model for Colorectal Cancer Screening: Potential of Stool Tests with Various Performance Characteristics Compared with Screening Colonoscopy

  2005cited by this paper
• A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.

  2005cited by this paper
• Vergleich verschiedener Stuhltests zur Detektion von Neoplasien des Kolon

  2005cited by this paper
• [Comparison of different stool tests for the detection of cancer of the colon].

  2005cited by this paper
• A Comparison of the Immunochemical Fecal Occult Blood Test and Total Colonoscopy in the Asymptomatic Population

  2005cited by this paper
• Methods and Economic Considerations: Group 1 Report

  2004cited by this paper
• Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer

  2004cited by this paper
• Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma

  2001cited by this paper
• One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.

  2001cited by this paper
• Natural history of colorectal cancer.

  1999cited by this paper
• A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult.

  1998cited by this paper
• A comparison of fecal occult-blood tests for colorectal-cancer screening.

  1996cited by this paper
• Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests.

  1993cited by this paper
• Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study.

  1992cited by this paper

• The emerging role of blood-based biomarkers in early detection of colorectal cancer: A systematic review.

  2025cites this paper
• Quantitative faecal immunochemical tests to guide colorectal cancer pathway referral in primary care. A systematic review, meta-analysis and cost-effectiveness analysis.

  2025cites this paper
• Pyruvate Kinase PKM2: Basic and Translational Aspects in Molecular Diagnosis of Human Malignancies

  2025cites this paper
• Diagnostic value of pyruvate kinase isoenzyme type M2 for colorectal cancer: Evidence from meta-analysis.

  2025cites this paper
• Stool and symptom testing in ColoREctal Evaluation for Neoplasia in Cystic Fibrosis (SCREEN-CF).

  2025cites this paper
• Evaluating the Efficacy of Fecal Immunochemical Test, Fecal Calprotectin, and Serum C-Reactive Protein in Diagnosing Patients With Chronic Lower Gastrointestinal Symptoms

  2024influential citation
• The performance of FIT-based and other risk prediction models for colorectal neoplasia in symptomatic patients: a systematic review

  2023cites this paper
• Comparison of faecal protein biomarkers' diagnostic accuracy for colorectal advanced neoplasms: a systematic review and meta-analysis

  2022cites this paper
• The role of faecal calprotectin in diagnosis and staging of colorectal neoplasia: a systematic review and meta-analysis

  2022cites this paper
• Biomarkers to Detect Early-Stage Colorectal Cancer

  2022cites this paper
• Variation of Positive Predictive Values of Fecal Immunochemical Tests by Polygenic Risk Score in a Large Screening Cohort

  2022cites this paper
• Faecal immunochemical test outside colorectal cancer screening?

  2021cites this paper
• Biomarkers as Putative Therapeutic Targets in Colorectal Cancer

  2021cites this paper
• Faecal immunochemical tests safely enhance rational use of resources during the assessment of suspected symptomatic colorectal cancer in primary care: systematic review and meta-analysis

  2021cites this paper
• Faecal immunochemical test to triage patients with possible colorectal cancer symptoms: meta-analysis

  2021cites this paper
• The role of faecal calprotectin in the identification of colorectal neoplasia in patients attending for screening colonoscopy

  2021cites this paper
• Results of Compliant Participation in 5 Rounds of Fecal Immunochemical Test Screening for Colorectal Cancer.

  2020cites this paper
• The Combined Value of Faecal Haemoglobin and Calprotectin in Diagnosis of Colorectal Cancer in Symptomatic Patients Referred to Colonoscopy

  2019cites this paper
• Ellipsometry Analytical Complex for Measuring near the Surface Plasmon Resonance in Colorectal Cancer Diagnosis

  2019cites this paper
• High-risk symptoms and quantitative faecal immunochemical test accuracy: Systematic review and meta-analysis

  2019cites this paper
• Using Decision Tree Aggregation with Random Forest Model to Identify Gut Microbes Associated with Colorectal Cancer

  2019cites this paper
• Novel biomarkers for the diagnosis and prognosis of colorectal cancer

  2019cites this paper
• Diagnostic accuracy of fecal calprotectin for screening patients with colorectal cancer: A meta-analysis.

  2018influential citation
• Diagnostic accuracy of one or two faecal haemoglobin and calprotectin measurements in patients with suspected colorectal cancer

  2018cites this paper
• Faecal Immunochemical Tests (FIT) for Haemoglobin for Timely Assessment of Patients with Symptoms of Colorectal Disease

  2018cites this paper
• The fecal immunochemical test (fit): Selected aspects regarding its effectiveness for colorectal cancer screening in Quebec City

  2018cites this paper
• Timely Diagnosis of Colorectal Cancer

  2017cites this paper
• Published diagnostic models safely excluded colorectal cancer in an independent primary care validation study.

  2017cites this paper
• Systematic evaluation of supervised classifiers for fecal microbiota-based prediction of colorectal cancer

  2017cites this paper
• Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.

  2017cites this paper
• Faecal immunochemical tests (FIT) can help to rule out colorectal cancer in patients presenting in primary care with lower abdominal symptoms: a systematic review conducted to inform new NICE DG30 diagnostic guidance

  2017influential citation
• Diagnosing colorectal cancer and inflammatory bowel disease in primary care: The usefulness of tests for faecal haemoglobin, faecal calprotectin, anaemia and iron deficiency. A prospective study

  2017influential citation
• Fecal Tumor M2-Pyruvate Kinase ™ (ScheBo Test) for Colorectal Cancer Detection in Adult Egyptians

  2017cites this paper
• Power of screening tests for colorectal cancer enhanced by high levels of M2-PK in addition to FOBT

  2017cites this paper
• Diagnosing colorectal cancer in primary care : the value of symptoms, faecal immunochemical tests, faecal calprotectin and anaemia

  2017cites this paper
• Precancerous Lesions in Gastrointestinal Tract

  2017cites this paper
• An investigation of volatile organic compounds as biomarkers for gastrointestinal neoplasia

  2017cites this paper
• Implementation of immunochemical faecal occult blood test in general practice: a study protocol using a cluster-randomised stepped-wedge design

  2016cites this paper
• Papel de la calprotectina fecal como predictor de enfermedad orgánica: aplicabilidad en la diarrea crónica y la recurrencia endoscópica de la enfermedad de Crohn

  2016cites this paper
• Faecal calprotectin in patients with suspected colorectal cancer: a diagnostic accuracy study.

  2016cites this paper
• Utilizzo del test per la quantificazione dell’M2-PK fecale nell’ambito di un programma di screening per il carcinoma colorettale in soggetti positivi al FIT

  2016cites this paper
• Development of an Intervention for Implementing Immunochemical Faecal Occult Blood Test in General Practice

  2016cites this paper
• Correlation between Faecal Tumour M2 Pyruvate Kinase and Colonoscopy for the Detection of Adenomatous Neoplasia in a Secondary Care Cohort.

  2016cites this paper
• The value of calprotectin S100A8/A9 complex as a biomarker in colorectal cancer: A systematic review.

  2016influential citation
• Evaluation of the Performance of a Fecal Tumor M2-PK Rapid Kit Using Stool Specimens for Detection of Colorectal Tumors.

  2016cites this paper
• Fecal Immunochemical Tests Combined With Other Stool Tests for Colorectal Cancer and Advanced Adenoma Detection: A Systematic Review

  2016cites this paper
• Colorectal cancer detection in an asymptomatic population: fecal immunochemical test for hemoglobin vs. fecal M2-type pyruvate kinase

  2016cites this paper
• A systematic review and meta-analysis of the diagnostic accuracy of pyruvate kinase M2 isoenzymatic assay in diagnosing colorectal cancer

  2015cites this paper
• University of Dundee Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms Mowat,

  2015cites this paper
• Colorectal cancer diagnosis: Pitfalls and opportunities.

  2015cites this paper
• Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms

  2015cites this paper
• Tumor M2-pyruvate kinase in stool as a biomarker for diagnosis of colorectal cancer: A meta-analysis.

  2014cites this paper
• The use of fecal calprotectin as a biomarker in gastrointestinal disease

  2014cites this paper
• Comparison of faecal M2-PK and FIT in a population-based bowel cancer screening cohort

  2014cites this paper
• Reply to Dr. Tursi

  2013cites this paper
• Colonoscopy by nurse endoscopists: the right answer for the growing demand for colonoscopy in clinical practice?

  2013cites this paper
• CTG-21-0520 1..8

  year unknowncites this paper